[MCOH-EH] Question about requiring TB medications for employees

Hudson, T. Warner TWHudson at mednet.ucla.edu
Sun Apr 3 10:32:50 PDT 2016


Important question. OH does not have budget to evaluate and treat LTBI in new hires and this is a leaky area.  My answers are below.

T. Warner Hudson, MD FACOEM, FAAFP
Medical Director, Occupational and Employee Health
UCLA Health System and Campus
Office 310.825.9146
Fax 310.206.4585
Pager 800.233.7231  ID 27132
E-mail twhudson at mednet.ucla.edu<mailto:twhudson at mednet.ucla.edu>
Website www.ohs.uclahealth.org<http://www.ohs.uclahealth.org>

From: MCOH-EH [mailto:mcoh-eh-bounces+twhudson=mednet.ucla.edu at mylist.net] On Behalf Of Kathy.Dayvault at dekalbmedical.org
Sent: Friday, April 01, 2016 1:39 PM
To: mcoh-eh at mylist.net
Cc: Cynthia.Holbrook at dekalbmedical.org
Subject: [MCOH-EH] Question about requiring TB medications for employees

I am hoping to hear from folks who work in healthcare facilities that are considered high risk for TB.

 I am wondering how you manage employees with positive Skin or IGRA tests (all positives not just conversions after a specific exposure) who have received recommendations for treatment for latent TB.

Here are my questions:

1. Do you refer employees with positive results for evaluation? Yes.  Assuming CXR and TB questionnaire are both negative, new hires at onboarding are sent with a letter to their own doctor, signed by OH and the employee with the positive TB test copy to chart, advising INH; and conversions are sent to Occupational Health internally where we cajole and get fairly good acceptance especially with the 3 mo of weekly rifapentine plus INH DOT.  Occasionally with high risk new hires we send to ID for added success as the PCPs tend not to place on INH and this has bitten UCLA once with a declined INH new hire 2007 RN who became active TB 2014 and exposure >100 employees and staff.
2. Are they required to go for eval - yes for conversions; the letter is explicit but we are not able to check that they followed up with PCP
3. If treatment is recommended, does the employee have the option of refusing treatment? yes but must sign declination form which is kept in chart
4. If treatment is refused by the employee, are there consequences associated with refusal? No other than the documented refusal in the chart     Consequences could include disciplinary action, removal from duty, termination or not allowing the employee to work in high risk areas.

I appreciate your time and feedback!

Thanks,

Kathy Dayvault, RN, BSN, MPH, COHN-S/CM
 Manager, Occupational Health and Safety
 WorksWell Onsite
 Dekalb Medical  2701 North Decatur Road
 Decatur, GA 30033
ph: 404.501.4972 Fax:404-501-2045
kathy.dayvault at dekalbmedical.org<mailto:kathy.dayvault at dekalbmedical.org>

CONFIDENTIALITY NOTICE: This e-mail, including attachments, is for the sole use of the individual(s) to whom it is addressed, and may contain confidential and privileged information, including HIPAA protected PHI. Any unauthorized review, use, disclosure, distribution, or reproduction is prohibited. If you have received this e-mail in error, please notify the sender by reply e-mail and destroy this message and its attachments in its entirety.

________________________________

UCLA HEALTH SCIENCES IMPORTANT WARNING: This email (and any attachments) is only intended for the use of the person or entity to which it is addressed, and may contain information that is privileged and confidential. You, the recipient, are obligated to maintain it in a safe, secure and confidential manner. Unauthorized redisclosure or failure to maintain confidentiality may subject you to federal and state penalties. If you are not the intended recipient, please immediately notify us by return email, and delete this message from your computer.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://mylist.net/archives/mcoh-eh/attachments/20160403/70491d17/attachment.html>


More information about the MCOH-EH mailing list